Top Markets
Coin of the day
Liminal BioSciences Inc. Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNL
Κατάταξη σε μετοχές #38952
Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm,... Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.
Τιμή μετοχής
$8.50
Τελευταίος συγχρονισμός: 2023-09-26
Κεφαλαιοποίηση
$719.10K
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
CA
Εμπόριο Liminal BioSciences Inc. (LMNL)

Κατηγορία

Ιστορικό τιμής μετοχής για την Liminal BioSciences Inc. (LMNL)
Υψηλότερη τιμή κλεισίματος: $8.45 στις 2023-09-01

Χαμηλότερη τιμή κλεισίματος: $1.69K στις 2009-12-01
Ιστορικό τιμής μετοχής της Liminal BioSciences Inc. από 2009 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2023 112.62%
2022 -61.46%
2021 -76.57%
2020 -35.75%
2019 -97.45%
2018 -73.89%
2017 -28.49%
2016 -38.09%
2015 36.88%
2014 102.93%
2013 334.33%
2012 40.83%
2011 23.59%
2010 -34.41%
2009 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$503.68 29.05%
US
$840.68 28.85%
NL
$725.45 6.21%
CH
$1.07K -6.40%
KR
$252.06 11.35%
BE